Over 600,000 bottles of the blood pressure medication ramipril have been recalled across the United States due to potential contamination concerns. The U.S. Food and Drug Administration (FDA) issued the recall after discovering that some ingredients used in the drug originated from an uninspected and unapproved manufacturing facility in India.
Ramipril is a commonly prescribed medication used by over 2.4 million Americans each year to manage high blood pressure (hypertension). It works by relaxing blood vessels, making it easier for the heart to pump blood and lowering overall blood pressure levels.
Although no adverse health events have been reported so far, the FDA has issued a cautionary warning. While the risk to public health is considered low, the use of ingredients from an unverified facility could pose a contamination threat that cannot be ignored.
The recall specifically targets ramipril capsules manufactured by Lupin Pharmaceuticals, a drug company based in India. The affected capsules are available in three different strengths: 2.5 mg, 5 mg, and 10 mg.
These capsules were distributed in bottle sizes containing 90, 100, or 500 capsules, with expiration dates extending to July 2026. Consumers are being urged to check their medication labels to identify if they possess any of the impacted batches.
Those who are currently taking the recalled medication are advised not to stop taking ramipril abruptly, as doing so can lead to a dangerous spike in blood pressure. Instead, they should consult their healthcare provider immediately for guidance and potential alternatives.
Pharmacies and medical providers have also been alerted and instructed to remove the affected products from their shelves. The FDA is continuing to monitor the situation and is working with Lupin Pharmaceuticals to ensure compliance and safety moving forward.
This recall serves as a reminder of the importance of stringent quality control in pharmaceutical manufacturing and the need for global transparency when it comes to public health and medication safety.
